News

Clinical Trials Arena on MSN21h
Sarepta refuses to pull gene therapy despite FDA order
Sarepta Therapeutics is refusing to pull its gene therapy Elevidys (delandistrogene moxeparvovec), despite a request from the FDA.
All Of The Products That We Gave HuffPicks Shopping Awards To This Year
HuffPicks is HuffPost’s shopping awards. This “seal of approval” showcases a mix of expert-backed recommendations, ...
The Cool Down on MSN5d
Outdoorsman shares clever hack using empty pill bottles: 'Great tip'
Got a ton of empty pill bottles and no clue what to do with them? YouTuber Appalachian Andy (@AppalachianAndyOutdoors) has a great tip for outdoorsy folks. The scoop This easy fire kit ...
Zacks Investment Research on MSN6d
Merck Starts Phase III Studies on Once-Monthly Pill for HIV Prevention
Merck MRK recently launched two late-stage clinical studies to evaluate MK-8527, its investigational once-monthly oral pill for HIV pre-exposure prophylaxis (PrEP). The EXPrESSIVE-11 study, which ...